Neos Therapeutics (NEOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 10,729 | 9,222 | 7,100 | 5,179 | 5,631 |
| Cost of Goods | 5,221 | 3,640 | 2,823 | 2,817 | 4,750 |
| Gross Profit | 5,508 | 5,582 | 4,277 | 2,362 | 881 |
| Operating Expenses | 18,247 | 17,314 | 19,109 | 19,531 | 16,719 |
| Operating Income | -12,518 | -11,092 | -14,009 | -16,352 | -15,088 |
| Interest Expense | 2,220 | 2,836 | 2,648 | 2,390 | 2,211 |
| Other Income | 302 | 276 | 403 | 97 | 78 |
| Pre-tax Income | -14,436 | -13,652 | -16,254 | -18,645 | -17,221 |
| Net Income Continuous | -14,436 | -13,652 | -16,254 | -18,645 | -17,221 |
| Net Income | $-14,436 | $-13,652 | $-16,254 | $-18,645 | $-17,221 |
| EPS Basic Total Ops | -0.50 | -0.38 | -0.58 | -0.82 | -0.88 |
| EPS Basic Continuous Ops | -0.50 | -0.37 | -0.58 | -0.82 | -0.88 |
| EPS Diluted Total Ops | -0.50 | -0.38 | -0.58 | -0.82 | -0.88 |
| EPS Diluted Continuous Ops | -0.50 | -0.37 | -0.58 | -0.82 | -0.88 |
| EBITDA(a) | $-11,489 | $-9,567 | $-13,026 | $-15,471 | $-14,264 |